Project Details
Description
A Phase 2, Single-Arm Study of the CXCR1/2 Inhibitor SX-682 Plus Enzalutamide in Men with Abiraterone-Resistant Metastatic Castration Resistant Prostate Cancer, the SYNERGY-201 Trial
| Status | Active |
|---|---|
| Effective start/end date | 11/1/23 → 11/30/33 |
Funding
- SYNTRIX BIOSYSTEMS INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.